KENNAMETAL INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that KENNAMETAL INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $1.97B | Aug 12, 2025 |
| FY2025 | Jun 30, 2024 | $2.05B | Aug 12, 2025 |
| FY2025 | Jun 30, 2023 | $2.08B | Aug 12, 2025 |
| FY2024 | Jun 30, 2022 | $2.01B | Aug 12, 2024 |
| FY2023 | Jun 30, 2021 | $1.84B | Aug 9, 2023 |
| FY2020 | Jun 30, 2020 | $379.05M | Aug 20, 2020 |
| FY2020 | Mar 31, 2020 | $483.08M | Aug 20, 2020 |
| FY2020 | Dec 31, 2019 | $505.08M | Aug 20, 2020 |
| FY2020 | Sep 30, 2019 | $518.09M | Aug 20, 2020 |
| FY2020 | Jun 30, 2019 | $603.95M | Aug 20, 2020 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Jun 30, 2018 | $646.12M | Aug 10, 2018 |
| FY2018 | Mar 31, 2018 | $607.94M | Aug 10, 2018 |
| FY2018 | Dec 31, 2017 | $571.35M | Aug 10, 2018 |
| FY2018 | Sep 30, 2017 | $542.45M | Aug 10, 2018 |
| FY2018 | Jun 30, 2017 | $565.03M | Aug 10, 2018 |
| FY2018 | Mar 31, 2017 | $528.63M | Aug 10, 2018 |
| FY2018 | Dec 31, 2016 | $487.57M | Aug 10, 2018 |
| FY2018 | Sep 30, 2016 | $477.14M | Aug 10, 2018 |
| FY2017 | Jun 30, 2016 | $521.22M | Aug 14, 2017 |
| FY2017 | Mar 31, 2016 | $497.84M | Aug 14, 2017 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $598.07M | Aug 12, 2025 |
| FY2025 | Jun 30, 2024 | $627.09M | Aug 12, 2025 |
| FY2025 | Jun 30, 2023 | $646.44M | Aug 12, 2025 |
| FY2024 | Jun 30, 2022 | $647.98M | Aug 12, 2024 |
| FY2023 | Jun 30, 2021 | $552.48M | Aug 9, 2023 |
| FY2020 | Jun 30, 2020 | $101.45M | Aug 20, 2020 |
| FY2020 | Mar 31, 2020 | $157.02M | Aug 20, 2020 |
| FY2020 | Dec 31, 2019 | $132.02M | Aug 20, 2020 |
| FY2020 | Sep 30, 2019 | $138.98M | Aug 20, 2020 |
| FY2020 | Jun 30, 2019 | $213.72M | Aug 20, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $93.13M | Aug 12, 2025 |
| FY2025 | Jun 30, 2024 | $109.32M | Aug 12, 2025 |
| FY2025 | Jun 30, 2023 | $118.46M | Aug 12, 2025 |
| FY2024 | Jun 30, 2022 | $144.62M | Aug 12, 2024 |
| FY2023 | Jun 30, 2021 | $54.43M | Aug 9, 2023 |
| FY2020 | Jun 30, 2020 | ($9.11M) | Aug 20, 2020 |
| FY2020 | Mar 31, 2020 | $2.92M | Aug 20, 2020 |
| FY2020 | Dec 31, 2019 | ($5.94M) | Aug 20, 2020 |
| FY2020 | Sep 30, 2019 | $6.47M | Aug 20, 2020 |
| FY2020 | Jun 30, 2019 | $61.98M | Aug 20, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $143.12M | Aug 12, 2025 |
| FY2025 | Jun 30, 2024 | $170.22M | Aug 12, 2025 |
| FY2025 | Jun 30, 2023 | $192.42M | Aug 12, 2025 |
| FY2024 | Jun 30, 2022 | $218.14M | Aug 12, 2024 |
| FY2023 | Jun 30, 2021 | $102.17M | Aug 9, 2023 |
| FY2022 | Jun 30, 2020 | $22.25M | Aug 10, 2022 |
| FY2021 | Jun 30, 2019 | $328.85M | Aug 10, 2021 |
| FY2020 | Jun 30, 2018 | $290.30M | Aug 20, 2020 |
| FY2019 | Jun 30, 2017 | $94.75M | Aug 13, 2019 |
| FY2018 | Jun 30, 2016 | ($174.94M) | Aug 10, 2018 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $44.40M | Aug 12, 2025 |
| FY2025 | Jun 30, 2024 | $44.20M | Aug 12, 2025 |
| FY2025 | Jun 30, 2023 | $43.10M | Aug 12, 2025 |
| FY2024 | Jun 30, 2022 | $42.10M | Aug 12, 2024 |
| FY2023 | Jun 30, 2021 | $39.50M | Aug 9, 2023 |
| FY2022 | Jun 30, 2020 | $38.70M | Aug 10, 2022 |
| FY2021 | Jun 30, 2019 | $39.00M | Aug 10, 2021 |
| FY2020 | Jun 30, 2018 | $38.90M | Aug 20, 2020 |
| FY2019 | Jun 30, 2017 | $38.00M | Aug 13, 2019 |
| FY2018 | Jun 30, 2016 | $39.40M | Aug 10, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $208.32M | Aug 12, 2025 |
| FY2025 | Jun 30, 2024 | $277.11M | Aug 12, 2025 |
| FY2025 | Jun 30, 2023 | $257.95M | Aug 12, 2025 |
| FY2024 | Jun 30, 2022 | ($181.44M) | Aug 12, 2024 |
| FY2023 | Jun 30, 2021 | $235.68M | Aug 9, 2023 |
| FY2022 | Jun 30, 2020 | $223.74M | Aug 10, 2022 |
| FY2021 | Jun 30, 2019 | $300.52M | Aug 10, 2021 |
| FY2020 | Jun 30, 2018 | $277.30M | Aug 20, 2020 |
| FY2019 | Jun 30, 2017 | $195.34M | Aug 13, 2019 |
| FY2018 | Jun 30, 2016 | $222.49M | Aug 10, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $88.97M | Aug 12, 2025 |
| FY2025 | Jun 30, 2024 | $107.56M | Aug 12, 2025 |
| FY2025 | Jun 30, 2023 | $94.39M | Aug 12, 2025 |
| FY2024 | Jun 30, 2022 | $96.92M | Aug 12, 2024 |
| FY2023 | Jun 30, 2021 | $127.30M | Aug 9, 2023 |
| FY2022 | Jun 30, 2020 | $244.15M | Aug 10, 2022 |
| FY2021 | Jun 30, 2019 | $212.34M | Aug 10, 2021 |
| FY2020 | Jun 30, 2018 | $171.00M | Aug 20, 2020 |
| FY2019 | Jun 30, 2017 | $118.02M | Aug 13, 2019 |
| FY2018 | Jun 30, 2016 | $110.70M | Aug 10, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $2.55B | Aug 12, 2025 |
| FY2025 | Jun 30, 2024 | $2.50B | Aug 12, 2025 |
| FY2025 | Jun 30, 2023 | $2.55B | Aug 12, 2025 |
| FY2024 | Jun 30, 2022 | $2.57B | Aug 12, 2024 |
| FY2023 | Jun 30, 2021 | $2.67B | Aug 9, 2023 |
| FY2022 | Jun 30, 2020 | $3.04B | Aug 10, 2022 |
| FY2021 | Jun 30, 2019 | $2.66B | Aug 10, 2021 |
| FY2020 | Jun 30, 2018 | $2.93B | Aug 20, 2020 |
| FY2019 | Jun 30, 2017 | $2.42B | Aug 13, 2019 |
| FY2018 | Jun 30, 2016 | $2.36B | Aug 10, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $1.22B | Aug 12, 2025 |
| FY2025 | Jun 30, 2024 | $1.22B | Aug 12, 2025 |
| FY2024 | Jun 30, 2023 | $1.23B | Aug 12, 2024 |
| FY2023 | Jun 30, 2022 | $1.28B | Aug 9, 2023 |
| FY2022 | Jun 30, 2021 | $1.30B | Aug 10, 2022 |
| FY2021 | Jun 30, 2020 | $1.77B | Aug 10, 2021 |
| FY2020 | Jun 30, 2019 | $1.28B | Aug 20, 2020 |
| FY2019 | Jun 30, 2018 | $1.70B | Aug 13, 2019 |
| FY2018 | Jun 30, 2017 | $1.36B | Aug 10, 2018 |
| FY2017 | Jun 30, 2016 | $1.37B | Aug 14, 2017 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $1.28B | Aug 12, 2025 |
| FY2025 | Jun 30, 2024 | $1.25B | Aug 12, 2025 |
| FY2024 | Jun 30, 2023 | $1.28B | Aug 12, 2024 |
| FY2023 | Jun 30, 2022 | $1.25B | Aug 9, 2023 |
| FY2022 | Jun 30, 2021 | $1.33B | Aug 10, 2022 |
| FY2021 | Jun 30, 2020 | $1.23B | Aug 10, 2021 |
| FY2020 | Jun 30, 2019 | $1.34B | Aug 20, 2020 |
| FY2019 | Jun 30, 2018 | $1.19B | Aug 13, 2019 |
| FY2018 | Jun 30, 2017 | $1.02B | Aug 10, 2018 |
| FY2017 | Jun 30, 2016 | $964.32M | Aug 14, 2017 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $282.73M | Aug 12, 2025 |
| FY2025 | Jun 30, 2024 | $271.57M | Aug 12, 2025 |
| FY2025 | Jun 30, 2023 | $269.55M | Aug 12, 2025 |
| FY2024 | Jun 30, 2022 | $264.23M | Aug 12, 2024 |
| FY2023 | Jun 30, 2021 | $277.62M | Aug 9, 2023 |
| FY2022 | Jun 30, 2020 | $270.58M | Aug 10, 2022 |
| FY2021 | Jun 30, 2019 | $300.01M | Aug 10, 2021 |
| FY2020 | Jun 30, 2018 | $301.80M | Aug 20, 2020 |
| FY2019 | Jun 30, 2017 | $301.37M | Aug 13, 2019 |
| FY2018 | Jun 30, 2016 | $298.49M | Aug 10, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $1.20B | Aug 12, 2025 |
| FY2025 | Jun 30, 2024 | $1.17B | Aug 12, 2025 |
| FY2024 | Jun 30, 2023 | $1.12B | Aug 12, 2024 |
| FY2023 | Jun 30, 2022 | $1.07B | Aug 9, 2023 |
| FY2022 | Jun 30, 2021 | $992.60M | Aug 10, 2022 |
| FY2021 | Jun 30, 2020 | $1.00B | Aug 10, 2021 |
| FY2020 | Jun 30, 2019 | $1.08B | Aug 20, 2020 |
| FY2019 | Jun 30, 2018 | $900.68M | Aug 13, 2019 |
| FY2018 | Jun 30, 2017 | $765.61M | Aug 10, 2018 |
| FY2017 | Jun 30, 2016 | $780.60M | Aug 14, 2017 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2024 | $127.97M | Aug 12, 2025 |
| FY2025 | Jun 30, 2023 | $106.02M | Aug 12, 2025 |
| FY2025 | Jun 30, 2022 | $85.59M | Aug 12, 2025 |
| FY2024 | Jun 30, 2021 | $154.05M | Aug 12, 2024 |
| FY2023 | Jun 30, 2020 | $606.68M | Aug 9, 2023 |
| FY2022 | Jun 30, 2019 | $182.02M | Aug 10, 2022 |
| FY2021 | Jun 30, 2018 | $556.15M | Aug 10, 2021 |
| FY2020 | Jun 30, 2017 | $190.63M | Aug 20, 2020 |
| FY2019 | Jun 30, 2016 | $161.58M | Aug 13, 2019 |
| FY2018 | Jun 30, 2015 | $105.49M | Aug 10, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | 1 | Aug 12, 2025 |
| FY2025 | Jun 30, 2024 | 1 | Aug 12, 2025 |
| FY2025 | Jun 30, 2023 | 1 | Aug 12, 2025 |
| FY2024 | Jun 30, 2022 | 1 | Aug 12, 2024 |
| FY2023 | Jun 30, 2021 | 0 | Aug 9, 2023 |
| FY2020 | Jun 30, 2020 | 0 | Aug 20, 2020 |
| FY2020 | Mar 31, 2020 | 0 | Aug 20, 2020 |
| FY2020 | Dec 31, 2019 | 0 | Aug 20, 2020 |
| FY2020 | Sep 30, 2019 | 0 | Aug 20, 2020 |
| FY2020 | Jun 30, 2019 | 0 | Aug 20, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | 1 | Aug 12, 2025 |
| FY2025 | Jun 30, 2024 | 1 | Aug 12, 2025 |
| FY2025 | Jun 30, 2023 | 1 | Aug 12, 2025 |
| FY2024 | Jun 30, 2022 | 1 | Aug 12, 2024 |
| FY2023 | Jun 30, 2021 | 0 | Aug 9, 2023 |
| FY2020 | Jun 30, 2020 | 0 | Aug 20, 2020 |
| FY2020 | Mar 31, 2020 | 0 | Aug 20, 2020 |
| FY2020 | Dec 31, 2019 | 0 | Aug 20, 2020 |
| FY2020 | Sep 30, 2019 | 0 | Aug 20, 2020 |
| FY2020 | Jun 30, 2019 | 0 | Aug 20, 2020 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $61.85M | Aug 12, 2025 |
| FY2025 | Jun 30, 2024 | $63.43M | Aug 12, 2025 |
| FY2025 | Jun 30, 2023 | $64.52M | Aug 12, 2025 |
| FY2024 | Jun 30, 2022 | $66.57M | Aug 12, 2024 |
| FY2023 | Jun 30, 2021 | $66.74M | Aug 9, 2023 |
| FY2022 | Jun 30, 2020 | $66.30M | Aug 10, 2022 |
| FY2021 | Jun 30, 2019 | $65.75M | Aug 10, 2021 |
| FY2020 | Jun 30, 2018 | $65.10M | Aug 20, 2020 |
| FY2019 | Jun 30, 2017 | $64.13M | Aug 13, 2019 |
| FY2018 | Jun 30, 2016 | $63.72M | Aug 10, 2018 |